Revenue Management for Life SciencesStrategies for improving revenue and margin performance |
Publish date:
A variety of changes have recently been observed in the life sciences industry: competition is increasing, customers are demanding more and better information and cost containment pressures are intensifying. Companies are no longer able to rely on traditional approaches to foster growth and minimize organizational risks. In order to combat these threats, companies must consider a number of strategic and operational changes to ensure that they can retain profitability while continuing to grow their companies and keep their customers happy. Explore the content below to learn how life sciences corporations can use Revenue Management best practices to create competitive advantage. For additional information, visit Strategies for Improving Revenue and Margin Performance.
The Six Emerging Strategic and Operational Decisions
Deloitte Service Offerings
Pricing and Reimbursement Strategies for the Medical Devices, Diagnostics and Laboratory Products Industry
In the face of heavy competition and a changing landscape, pricing strategy has evolved. By building a rigorous, data-driven pricing strategy and the infrastructure to sustain it, companies are poised to improve segmentation, pricing management and value capture through the product lifecycle.
Pricing and Reimbursement Strategies for the Pharmaceutical and Biotechnology Industry
By embracing end-to-end strategic pricing initiatives based on value-driven capabilities, companies can see tangible results even in the face of changing market dynamics.
Managed Care and Contracting Strategy for the Life Sciences Industry
A rigorous and systematic approach to managed care and contracting Strategy can enable life sciences companies to be more responsive to changing market pressures and turn contracting into a competitive advantage.
Trade / Distribution Strategies for the Pharmaceutical and Biotechnology Industry
A changing landscape has forced a focus on enterprise-wide revenue growth. Distribution models are being redefined to extract greater value, leading to the emergence of a fee-for-service (FFS) model that benefits both manufacturers and distributors.
Contract Administration, Rebates, and Chargebacks for the Life Sciences Industry
Aggressive and increasingly complicated contracting has exposed companies to profit leakage as their processing capabilities have failed to keep up. By building capabilities in contract administration, companies facilitate compliance and create opportunities to improve the bottom line.
Customer and Reimbursement Support for the Life Sciences Industry
As the U.S. health system takes an increasingly consumer-driven direction, life sciences companies have the opportunity to gather critical information, generate additional revenue, and foster goodwill by embracing the full potential of customer and reimbursement support.
Related Insight
 |
Article: Life Sciences & Health Care Customer Support and Reimbursement Services
|
 |
Article: Smoother Sailing in the Distribution Channel
|
 |
Article: Revenue Management for Life Sciences
|
Stay Updated
Subscribe to receive updates from Deloitte's Life Sciences practice:
E-mail | 
RSS ( What is RSS?) | 
Twitter
As used in this document, "Deloitte" means Deloitte Consulting LLP, a subsidiary of Deloitte LLP. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries.
Last updated